BIOWAIVERS & BIOSIMILARS
October 27 - 29
 |
| Colin Shannon |
Biosimilars International Conference-2014 provides an in-depth
discussion of key industry issues essential to biosimilars including
cost effectual development and progression of methods, operation of
clinical trials, appraising safety and quality, key strategies for
dissolution testing, overcoming regulatory and legal issues and
achieving access to emerging markets and commercialising biosimilars.
Speaker: Rodeina Challand (Executive Director, Biosimilar Development)
Presentation: Challenges in Demonstrating
Biosimilarity and Interchangeability of Biosimilar Products and keynote
address Biosimilars in Emerging Markets: Regulatory and Commercial
Considerations.
No comments:
Post a Comment